Abstract
The use of nutraceuticals as pharmacotherapies aids used in the treatment of bipolar disorder (BD) has been evaluated in recent years. The purpose of this review is to examine the current level of evidence regarding the effectiveness of nutraceuticals as an adjunct to drug therapy in the treatment of BD. MethodologyA comprehensive search of publications on bipolar and nutraceuticals disorder bases Data were: PubMed / Medline, PsycINFO, Cochrane Library, using related nutraceuticals and BD in April 2016 in terms according to sanitary protocol PRISMA, test Guidelines (Moher, Liberati, Tetzlaff, & Altman, 2009; Urrútia and Bofill, 2010). This proposal provides guidance for optimal reporting of systematic review protocols. ResultsThe evidence is inconclusive. In some cases it is suggested that the treatment in BD could potentially be improved by the additional use of certain nutraceuticals combined with traditional drug therapy. DiscussionThere is no consensus regarding the use of nutraceuticals as adjunctive therapy to pharmacological therapy in BD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
